Integrated DNA Technologies (IDT) has unveiled a new product aimed at accelerating pharmaceutical research. According to a release, “rapid genes” provide pre-assembled, ready-to-use DNA sequences ranging from 125 to 2,000 base pairs (bp) in length. These sequences, verified through next-generation…